Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genes regulated by CREB1 in LPS-primed THP1 monocytes

ABSTRACT: Genes regulated by CREB1 in LPS-primed THP1 monocytes

PROVIDER: PRJNA955033 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24152400.fastq.gz	Fastqsanger.gz
	SRR24152401.fastq.gz	Fastqsanger.gz
	SRR24152402.fastq.gz	Fastqsanger.gz
	SRR24152403.fastq.gz	Fastqsanger.gz
	SRR24152392.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Genes regulated by CREB1 in LPS-primed THP1 monocytes

Project description:To screen the genes and pathways regulated by CREB1 in the THP1 monocytes induced by LPS, THP1 monocytes were transfected by CREB1 shRNA and then treated by LPS for 3 hours.

2023-04-14 | GSE229580 | GEO

Decoding the gene promoters binding with BRD3 in LPS-primed THP1 monocytes

Project description:To screen the genes regulated by BRD3 in the THP1 monocytes induced by LPS, THP1 monocytes were treated by LPS for 1 hour in the presence or absence of OTX015

2023-12-31 | GSE234162 | GEO

Decoding the gene promoters binding with BRD3 in LPS-primed THP1 monocytes

Project description:Decoding the gene promoters binding with BRD3 in LPS-primed THP1 monocytes

| PRJNA980218 | ENA

Quantitative proteomic analysis of human monocytes (THP1)

Project description:To observe the changes of protein expression in human monocytes (THP1) infected with adenovirus.

2023-02-06 | PXD039874 |

RNA-seq of CYR61-treated THP1 human monocytes

Project description:We assess the effects of CYR61 treatment on the transcriptome of human THP1 monocytes.

2023-10-18 | GSE233125 | GEO

Analysis of lncrna expression profile in LPS activated THP1 cells

Project description:In order to further explore the expression of lncrna in asthma, we used lipopolysaccharide (LPS) to activate human monocyte macrophage THP-1, and then used deep sequencing method to detect the expression of lncrna in activated and inactive THP1 cells. The results showed that there were different expression of lncrna in LPS activated and inactive THP1 cells

2021-12-23 | GSE174197 | GEO

The effect of MPO-ANCA on LPS-primed human monocytes

Project description:Human monocytes treated with LPS and MPO-ANCA or control IgG

2017-08-23 | GSE89153 | GEO

Glycoproteomes of naive and LPS stimulated human monocytes and THP-1 cells

Project description:CD14+ Monocytes from healthy volunteers were purified by MACS (negative selection) and FACSorting and either left untreated or stimulated for 24h and 48h with LPS. THP-1 cells were stimulated for 4h, 24h and 48h with LPS. Glycoproteins were captured with hydrazide chemistry and tryptic and PNGase F-released peptide fractions analyzed by MS/MS. Quantitative assessment revealed differential glycoprotein expression in activated/LPS-tolerized monocytes and naïve monocytes and THP-1 cells.

2017-04-24 | PXD004034 | Pride

Chip-chip from THP1 cells with Pol II, Pol II Ser5-P, H3K9Ac and from primary monocytes with H3K4Me3

Project description:THP1 cells were ChIPed with indicated antibodies. Comparison of selected chromatin marks in THP1 cells and monocytes

2013-02-15 | E-GEOD-43870 | biostudies-arrayexpress

RNA-seq of non-LPS treated (N), non-tolerized (NT), and tolerized (T) IFNg-primed macrophages pretreated with or without HDAC3i

Project description:In this experiment we investigated the effect of HDAC3 inhibition on the transcriptome of IFNg-primed macrophages under different tolerization conditions. Peripheral blood mononuclear cells (PBMCs) were isolated from 3 healthy donors. PBMCs were isolated from whole blood of healthy donors using Ficoll gradient (Invitrogen). Monocytes (CD14+ cells) were positively selected from PBMCs using CD14 Microbeads according to the manufacturer’s instructions (Miltenyi Biotec). Monocytes were subsequently treated with or without 500 nM HDAC3i (ITF3100) for 30 minutes prior to overnight IFNg priming (50 ng/mL). Cells were then kept without LPS (non-LPS; N), treated with 10 ng/mL LPS once (non-tolerized; NT), or treated with LPS twice (tolerized; T; second LPS concentration: 100 ng/mL).

2020-02-12 | E-MTAB-8784 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data